大家在查：审判庭鞠躬史迪威头目 paced 金扬里克福克斯 a young fall off 2030年

赛诺菲

网络Sanofi; SNY; Sanofi-Aventis

赛诺菲

网络释义

赛诺菲

Sanofi

赛诺菲（Sanofi）日前宣布，在骨髓纤维化（myelofibrosis，MF）患者中开展的有关选择性JAK2抑制剂SAR302503的关键性III …

SNY

去年，在赛诺菲（SNY）开始培训中国员工之后，诺和诺德公司的Schultz在Bloomberg网站回应称：“人们将看到：诺和诺德公 …

Sanofi-Aventis

8月，法国生物制药公司赛诺菲（Sanofi-Aventis）公开表明欲以185亿美元收购健赞（Genzyme）公司。英特尔（Intel）也于8 …

SANOFI AVENTIS US

欢迎访问《中国药科大学学报》！ ... Pfizer Inc( 辉瑞) Sanofi Aventis Us( 赛诺菲) Linaclotide( 利那洛肽) ...

Sanofi-Pasteur

法国原本向法商赛诺菲（Sanofi-Pasteur）和荷商GSK等公司订购9400万剂疫苗，计画为大多数人口施打两剂H1N1疫苗，后来 …

Sanofi SA

赛诺菲(Sanofi SA)未来五年预计将在中国实现两位数的增长中国的学生从小就被教导要寻求稳定，规避风险中国向生产更高端 …

SASY.PA

欧洲股市周四收涨,受药商赛诺菲(SASY.PA)和消费品集团联合利华(ULVR.L)发布乐观财测带动,但部分交易商认为,对欧元区的 …

SANOFI-TOPAZ INC

2012年2月FDA批准新药概况... ... IVERMECTIN( 伊维菌素) SANOFI-TOPAZ INC( 赛诺菲) BALSALAZIDE DISODIUM( 巴柳氮 …

例句：

The FDA has interacted with the company throughout the regulatory process to help ensure compliance with applicable requirements .

FDA 已通过规定程序与赛诺菲 •巴斯德公司进行了协调，以保证遵守可适用的要求。

Sanofi spokeswoman Emmy Tsui said the company was "committed to the safe and effective use of Eligard" and was reviewing the FDA request .

赛诺菲发言人艾美 .奖翠表示，该公司正按照 FDA 的要求，“致力于醋酸亮丙瑞林使用的安全性和有效性研究 ”。

Just yesterday , Sanofi-Aventis said it was abandoning its drug Acomplia, which had been approved in Europe to treat obesity .

就在昨天，赛诺菲安万特宣布放弃其药物 Acomplia ，其已获欧洲批准用于治疗肥胖症。

The company wants to expand the number of cooperative agreements it has with universities and government research institutes .

赛诺菲安万特希望能增加与高校和政府研究机构之间的合作协议。

Sanofi and other drugmakers annually produce about 300 million doses of seasonal flu vaccines, the kind used for annual flu shots.

赛诺菲和其它的制药企业每年生产 3亿支季节性感冒疫苗 --那种每年注射一次的疫苗。

WHO officials "are convinced that the seasonal influenza vaccine is just as important , " the Sanofi Pasteur spokesman says .

世卫组织官员确信，”季节性流感疫苗也是同样重要的，“赛诺菲巴斯德的这位发言人说。

Analysts believe Sanofi could be waiting for a final safety review for TroVax, due in the next few months .

分析家相信赛诺菲在等待关于 TroVax 的最终安全评估，该评估将在近几个月公布。

Later, Sanofi withdrew its marketing application and said it would resubmit the drug for approval as a diabetes treatment in 2009 .

赛诺菲撤出它的市场申请并且宣称将在 2009年作为一种糖尿病的治疗方案再次提出申请批准。

Sanofi's share price has come under pressure lately as a result of its acquisition of biotech giant Genzyme.

由于收购了生物科技界巨头 Genzyme ，赛诺菲的股价最近承受着压力。

Sanofi trades at a cheap eight times likely earnings over the next 12 months , with a dividend yield of 3 . 6%.

赛诺菲目前的估值便宜，仅相当于未来 12个月预测收益的 8 倍，股息收益率为 3 .

France's Sanofi-Aventis SA, meanwhile, is carrying out large clinical trials of an oral MS drug called teriflunomide.

法国制药公司赛诺菲 -安万特同时也在就自己的治疗多发性硬化症的口服药物 teriflunomide 的大型临床试验。

Roche , Merck and Sanofi persevered, testing thousands of molecules .

罗氏、默克集团、赛诺菲并没有放弃，继续试验数以千计的分子。

Unfortunately, to make those decisions, Sanofi-Pasteur and its partners need epidemiological information that is currently unavailable .

要做出这些决定，赛诺菲 -巴斯德及其合作伙伴需要获得流行病学信息，但遗憾的是，目前欠缺这样的信息。

Sanofi-aventis made its announcement of the donation of 100 million doses of vaccine at the Pacific Health Summit in Seattle, USA.

赛诺菲 -安万特公司是在美国西雅图召开的太平洋卫生峰会上宣布捐赠 1亿剂疫苗的。

Today , sanofi pasteur reinvests some 17 percent of its revenues into research and development.

今天，赛诺菲巴斯德投入公司收入的 17%用于疫苗的研发。

Just last week , Sanofi received FDA approval to manufacture seasonal flu vaccine at a new facility in Swiftwater, Pa.

就在上个星期，赛诺菲收到 FDA 许可在斯威沃特的新的工厂生产季节性流感疫苗。

If it meets certain milestones , it has the option to force Sanofi to buy it.

如果此项目到达某些里程碑，是可以要求赛诺菲收购它的。

He says Sanofi isn't -- 'to my knowledge' -- in active acquisition talks .

他说，就他所知，赛诺菲安万特目前没有在进行并购谈判。

The leading flu -vaccine manufacturers include Sanofi and Novartis.

领先的流感疫苗生产商包括赛诺菲和诺华。

Makers include Sanofi-Aventis (SASY. PA: Quote , Profile , Research) and several generic companies.

制造商包括赛诺菲安万特（（SASY.PA ：引用，轮廓，研究以及一些基因公司。

Separately, Sanofi said that a new daily treatment for multiple sclerosis taken by mouth met its primary endpoint in a phase III trial .

此外，赛诺菲安万特集团还表示，治疗多发性硬化症的新型口服药物在第三期临床试验中满足了主要终点。

Europe 's Sanofi Pasteur and Novartis are leading producers that use this approach .

欧洲赛诺菲和诺华制药在该种疫苗生产中处于领军地位。

Sanofi is an industry leader in blood -thinning drugs .

赛诺菲安万特是血液稀释剂方面的行业领军者。

However , work has slowed as Acambis is absorbed by a new owner , French vaccine giant Sanofi-Pasteur.

然而，这项工作已经放缓，因为 Acambis 公司被新东家法国疫苗巨头赛诺菲巴斯德收购。

赛诺菲

赛诺菲